Precision Medicine is All Rage Lately
The healthcare industry is undergoing a major transformation with scientific breakthroughs and technological advancements changing the way we diagnose and treat diseases. Health and life sciences organizations are leveraging diverse data collected through advanced technologies and tools for personalizing medical outcomes, which has led to the rising application of precision medicine for various interventions. Precision medicine tools and technologies such as molecular diagnostics, molecular imaging, big data, artificial intelligence, pharmaco-omics, etc. are helping alleviate unnecessary suffering that can result from the current one-size-fits-all approach. Precision medicine can help eliminate ineffective treatment plans at outset based on data insights and select treatments based on the genomic understanding of patient’s diseases.
Precision Medicine for Chronic Diseases
Chronic diseases affect millions of
people around the world and the number is expected to rise exponentially in the
future. Since chronic diseases are biologically complex and heterogenous from
how they present over time with different symptoms, there have not been many
developments or innovations in terms of diagnosis and treatments of the
metabolic disorders. Improving patient outcomes require targeting treatment to
specific person based on their health conditions and genetic morbidities. However,
precision medicine approach can help to uncover knowledge through important
disease insights that will enable one to identify novel drug targets with high
probability of success, identify biomarkers to characterize patients into
subgroups, support design of better clinical trials, and develop diagnostic
test to guide treatment in the real world.
Get Free Sample Report@ https://www.techsciresearch.com/sample-report.aspx?cid=4684
Precision Medicine for Oncology
Nearly 1.5% of the population and 20%
of patients with advanced cancer carry the risk of pathogenic variant. Understanding
the genomic basis for each patient’s diseases can help select right therapies
to manage patient’s cancer, which is the essence of applied precision medicine.
Comprehensive genomic profiling uses single assay to assess relevant cancer
biomarkers and find the best treatment possible to improve survival rate and
cost of care. Assessing hereditary cancer risks can also help support
prevention to reduce likelihood of developing cancer and susceptibility. Risk-stratified
breast cancer screening could result in 31% less fatalities. GE Healthcare is
advancing the future of medicine with innovative suite of precision,
predictive, and prescriptive technologies to improve detection and outcomes for
cancer patients.
Precision Medicine for Personalized
Diet
Just like every person responds to
medications, they also respond differently to the same foods. Many research
studies indicate that glycemic index is not sufficient enough to predict how
foods will affect an individual’s blood glucose levels. However, feeding data
and other personal information can help design custom diets based on the
individual’s predicted blood-sugar responses. Customized diets include more of
what an individual likes to eat as per their body goals, metabolism, weight,
and other factors. Compared to diets designed by dieticians, precision
medicines can help millions of people living with diabetes or prediabetes.
Key players operating in the global
precision medicine market such as Amgen Inc., F. Hoffman La Roche, Novartis AG,
Bayer AG, Merck & Co., Eli Lily and Company, Pfizer Inc., Abbott
Laboratories, and others are trying to increase their product pipeline by
filing new molecule applications or finding existing molecules.
Comments
Post a Comment